{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T16:19:17Z","timestamp":1792081157301,"version":"4.4.0"},"reference-count":129,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,3,20]],"date-time":"2019-03-20T00:00:00Z","timestamp":1553040000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["kidney-international.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.kint.2019.02.022","type":"journal-article","created":{"date-parts":[[2019,4,30]],"date-time":"2019-04-30T17:30:19Z","timestamp":1556645419000},"page":"1304-1317","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":425,"title":["Heart failure in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference"],"prefix":"10.1016","volume":"95","author":[{"given":"Andrew A.","family":"House","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Wanner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark J.","family":"Sarnak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ileana L.","family":"Pi\u00f1a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher W.","family":"McIntyre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Komenda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bertram L.","family":"Kasiske","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita","family":"Deswal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher R.","family":"deFilippi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John G.F.","family":"Cleland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan D.","family":"Anker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles A.","family":"Herzog","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Cheung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David C.","family":"Wheeler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang C.","family":"Winkelmayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter A.","family":"McCullough","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali K.","family":"Abu-Alfa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerstin","family":"Amann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazutaka","family":"Aonuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence J.","family":"Appel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin","family":"Baigent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George L.","family":"Bakris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debasish","family":"Banerjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John N.","family":"Boletis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biykem","family":"Bozkurt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javed","family":"Butler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher T.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Rosa","family":"Costanzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth F.","family":"Dubin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerasimos","family":"Filippatos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Betty M.","family":"Gikonyo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan K.","family":"Gikonyo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger J.","family":"Hajjar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunitoshi","family":"Iseki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Ishii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Greg A.","family":"Knoll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin R.","family":"Lenihan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krista L.","family":"Lentine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edgar V.","family":"Lerma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Etienne","family":"Macedo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick B.","family":"Mark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eisei","family":"Noiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Palazzuoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Pecoits-Filho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bertram","family":"Pitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Rigatto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Rossignol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soko","family":"Setoguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manish M.","family":"Sood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"St\u00f6rk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita S.","family":"Suri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karolina","family":"Szummer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sydney C.W.","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Navdeep","family":"Tangri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aliza","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krishnaswami","family":"Vijayaraghavan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Walsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela Yee-Moon","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew R.","family":"Weir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.kint.2019.02.022_bib1","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0735-1097(01)01700-4","article-title":"Confirmation of a heart failure epidemic: findings from the Resource Utilization Among Congestive Heart Failure (REACH) study","volume":"39","author":"McCullough","year":"2002","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.kint.2019.02.022_bib2","doi-asserted-by":"crossref","first-page":"e0158765","DOI":"10.1371\/journal.pone.0158765","article-title":"Global prevalence of chronic kidney disease\u2014a systematic review and meta-analysis","volume":"11","author":"Hill","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.kint.2019.02.022_bib3","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.ahj.2004.03.042","article-title":"Slowing the progression of diabetic nephropathy and its cardiovascular consequences","volume":"148","author":"McCullough","year":"2004","journal-title":"Am Heart J"},{"key":"10.1016\/j.kint.2019.02.022_bib4","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1159\/000349966","article-title":"Pathophysiology of the cardiorenal syndromes: executive summary from the eleventh consensus conference of the Acute Dialysis Quality Initiative (ADQI)","volume":"182","author":"McCullough","year":"2013","journal-title":"Contrib Nephrol"},{"key":"10.1016\/j.kint.2019.02.022_bib5","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1159\/000349969","article-title":"Pathogenesis of cardiorenal syndrome type 1 in acute decompensated heart failure: workgroup statements from the eleventh consensus conference of the Acute Dialysis Quality Initiative (ADQI)","volume":"182","author":"Haase","year":"2013","journal-title":"Contrib Nephrol"},{"key":"10.1016\/j.kint.2019.02.022_bib6","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1159\/000349968","article-title":"Pathophysiology of cardiorenal syndrome type 2 in stable chronic heart failure: workgroup statements from the eleventh consensus conference of the Acute Dialysis Quality Initiative (ADQI)","volume":"182","author":"Cruz","year":"2013","journal-title":"Contrib Nephrol"},{"key":"10.1016\/j.kint.2019.02.022_bib7","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1159\/000349971","article-title":"Cardiorenal syndrome type 3: pathophysiologic and epidemiologic considerations","volume":"182","author":"Bagshaw","year":"2013","journal-title":"Contrib Nephrol"},{"key":"10.1016\/j.kint.2019.02.022_bib8","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1159\/000349972","article-title":"Cardiorenal syndrome type 4: insights on clinical presentation and pathophysiology from the eleventh consensus conference of the Acute Dialysis Quality Initiative (ADQI)","volume":"182","author":"Tumlin","year":"2013","journal-title":"Contrib Nephrol"},{"key":"10.1016\/j.kint.2019.02.022_bib9","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1159\/000349970","article-title":"Cardiorenal syndrome type 5: clinical presentation, pathophysiology and management strategies from the eleventh consensus conference of the Acute Dialysis Quality Initiative (ADQI)","volume":"182","author":"Mehta","year":"2013","journal-title":"Contrib Nephrol"},{"key":"10.1016\/j.kint.2019.02.022_bib10","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s10741-014-9460-9","article-title":"Chronic kidney disease and cardiovascular complications","volume":"20","author":"Di Lullo","year":"2015","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.kint.2019.02.022_bib11","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.2215\/CJN.02920313","article-title":"Cardiorenal syndrome: new developments in the understanding and pharmacologic management","volume":"8","author":"House","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2019.02.022_bib12","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","volume":"37","author":"Ponikowski","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.kint.2019.02.022_bib13","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1053\/j.ackd.2017.07.003","article-title":"Treatment of disorders of sodium balance in chronic kidney disease","volume":"24","author":"Ellison","year":"2017","journal-title":"Adv Chronic Kidney Dis"},{"key":"10.1016\/j.kint.2019.02.022_bib14","first-page":"1","article-title":"KDIGO 2012 clinical practice guidelines for the evaluation and managment of chronic kidney disease","volume":"3","year":"2013","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.kint.2019.02.022_bib15","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1681\/ASN.2006101159","article-title":"Reduced kidney function as a risk factor for incident heart failure: the Atherosclerosis Risk in Communities (ARIC) study","volume":"18","author":"Kottgen","year":"2007","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2019.02.022_bib16","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1161\/CIRCULATIONAHA.105.580506","article-title":"Renal function as a predictor of outcome in a broad spectrum of patients with heart failure","volume":"113","author":"Hillege","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.kint.2019.02.022_bib17","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1161\/CIRCOUTCOMES.113.000221","article-title":"Chronic kidney disease and outcomes in heart failure with preserved versus reduced ejection fraction: the Cardiovascular Research Network PRESERVE Study","volume":"6","author":"Smith","year":"2013","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.kint.2019.02.022_bib18","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1002\/ejhf.821","article-title":"Associations with and prognostic impact of chronic kidney disease in heart failure with preserved, mid-range, and reduced ejection fraction","volume":"19","author":"Lofman","year":"2017","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.kint.2019.02.022_bib19","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1161\/CIRCHEARTFAILURE.111.966242","article-title":"Renal dysfunction in patients with heart failure with preserved versus reduced ejection fraction: impact of the new Chronic Kidney Disease-Epidemiology Collaboration Group formula","volume":"5","author":"McAlister","year":"2012","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.kint.2019.02.022_bib21","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1525-139X.2011.01011.x","article-title":"Diastolic heart failure in dialysis patients: mechanisms, diagnostic approach, and treatment","volume":"25","author":"Pecoits-Filho","year":"2012","journal-title":"Semin Dial"},{"key":"10.1016\/j.kint.2019.02.022_bib22","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1093\/eurheartj\/ehx045","article-title":"Long-term cardiovascular changes following creation of arteriovenous fistula in patients with end stage renal disease","volume":"38","author":"Reddy","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.kint.2019.02.022_bib23","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1016\/j.kint.2018.02.006","article-title":"Improving the prognosis of patients with severely decreased glomerular filtration rate (CKD G4+): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference","volume":"93","author":"Eckardt","year":"2018","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2019.02.022_bib24","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.cardfail.2007.03.011","article-title":"High prevalence of renal dysfunction and its impact on outcome in 118,465 patients hospitalized with acute decompensated heart failure: a report from the ADHERE database","volume":"13","author":"Heywood","year":"2007","journal-title":"J\u00a0Card Fail"},{"key":"10.1016\/j.kint.2019.02.022_bib25","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.pcad.2015.05.007","article-title":"Low fitness in midlife: a novel therapeutic target for heart failure with preserved ejection fraction prevention","volume":"58","author":"Pandey","year":"2015","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.kint.2019.02.022_bib26","first-page":"167","article-title":"Influence of myocardial ischemia on outcomes in patients with systolic versus non-systolic heart failure","volume":"1","author":"Vanhecke","year":"2011","journal-title":"Am J Cardiovasc Dis"},{"key":"10.1016\/j.kint.2019.02.022_bib27","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1007\/s11886-010-0101-1","article-title":"Myocardial ischemia in patients with diastolic dysfunction and heart failure","volume":"12","author":"Vanhecke","year":"2010","journal-title":"Curr Cardiol Rep"},{"key":"10.1016\/j.kint.2019.02.022_bib28","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/ejhf.445","article-title":"Association of chronic kidney disease with abnormal cardiac mechanics and adverse outcomes in patients with heart failure and preserved ejection fraction","volume":"18","author":"Unger","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.kint.2019.02.022_bib29","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s10741-014-9447-6","article-title":"Use of BNP and NT-proBNP for the diagnosis of heart failure in the emergency department: a systematic review of the evidence","volume":"19","author":"Hill","year":"2014","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.kint.2019.02.022_bib30","doi-asserted-by":"crossref","first-page":"515","DOI":"10.2215\/CJN.03600414","article-title":"Utility of traditional circulating and imaging-based cardiac biomarkers in patients with predialysis CKD","volume":"10","author":"Colbert","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2019.02.022_bib31","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1053\/j.ajkd.2005.04.007","article-title":"N-terminal pro-B-type natriuretic peptide for predicting coronary disease and left ventricular hypertrophy in asymptomatic CKD not requiring dialysis","volume":"46","author":"DeFilippi","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.kint.2019.02.022_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1527-5299.2004.03271.x","article-title":"BNP Consensus Panel 2004: a clinical approach for the diagnostic, prognostic, screening, treatment monitoring, and therapeutic roles of natriuretic peptides in cardiovascular diseases","volume":"10","author":"Silver","year":"2004","journal-title":"Congest Heart Fail"},{"key":"10.1016\/j.kint.2019.02.022_bib33","doi-asserted-by":"crossref","first-page":"200","DOI":"10.3909\/ricm0624","article-title":"Galectin-3: a novel blood test for the evaluation and management of patients with heart failure","volume":"12","author":"McCullough","year":"2011","journal-title":"Rev Cardiovasc Med"},{"key":"10.1016\/j.kint.2019.02.022_bib34","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1016\/j.jacc.2014.01.020","article-title":"Proposal for a functional classification system of heart failure in patients with end-stage renal disease: proceedings of the acute dialysis quality initiative (ADQI) XI workgroup","volume":"63","author":"Chawla","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.kint.2019.02.022_bib35","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1136\/hrt.2005.074583","article-title":"Use of chest radiography in the emergency diagnosis of acute congestive heart failure","volume":"92","author":"Mueller-Lenke","year":"2006","journal-title":"Heart"},{"key":"10.1016\/j.kint.2019.02.022_bib36","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/j.jacc.2015.11.065","article-title":"Influence of chronic renal failure on cardiac structure","volume":"67","author":"McCullough","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.kint.2019.02.022_bib37","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1053\/j.ackd.2004.11.002","article-title":"Changes in B-type natriuretic peptide levels in hemodialysis and the effect of depressed left ventricular function","volume":"12","author":"Safley","year":"2005","journal-title":"Adv Chronic Kidney Dis"},{"key":"10.1016\/j.kint.2019.02.022_bib38","first-page":"777","article-title":"Stable coronary artery disease and left ventricular dysfunction: the role of revascularization","volume":"90","author":"Aksut","year":"2017","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.kint.2019.02.022_bib39","doi-asserted-by":"crossref","first-page":"e003613","DOI":"10.1161\/CIRCHEARTFAILURE.116.003613","article-title":"Effect of intensive blood pressure treatment on heart failure events in the systolic blood pressure reduction intervention trial","volume":"10","author":"Upadhya","year":"2017","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.kint.2019.02.022_bib40","doi-asserted-by":"crossref","first-page":"989","DOI":"10.2215\/CJN.07800811","article-title":"Long-term renal and cardiovascular outcomes in Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) participants by baseline estimated GFR","volume":"7","author":"Rahman","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2019.02.022_bib41","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1056\/NEJMoa011161","article-title":"Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy","volume":"345","author":"Brenner","year":"2001","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.kint.2019.02.022_bib42","article-title":"Risk factors for heart failure in patients with chronic kidney disease: the CRIC (Chronic Renal Insufficiency Cohort) study","volume":"6","author":"He","year":"2017","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.kint.2019.02.022_bib43","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0140-6736(18)32824-1","article-title":"Pump, pipes, and filter: do SGLT2 inhibitors cover it all?","volume":"393","author":"Verma","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.kint.2019.02.022_bib44","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(18)32590-X","article-title":"SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials","volume":"393","author":"Zelniker","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.kint.2019.02.022_bib45","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1056\/NEJMoa1504720","article-title":"Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes","volume":"373","author":"Zinman","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.kint.2019.02.022_bib46","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1161\/CIRCULATIONAHA.117.028268","article-title":"Empagliflozin and clinical outcomes in patients with type 2 diabetes mellitus, established cardiovascular disease, and chronic kidney disease","volume":"137","author":"Wanner","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.kint.2019.02.022_bib47","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1056\/NEJMoa1611925","article-title":"Canagliflozin and cardiovascular and renal events in type 2 diabetes","volume":"377","author":"Neal","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.kint.2019.02.022_bib48","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1056\/NEJMoa1812389","article-title":"Dapagliflozin and cardiovascular outcomes in type 2 diabetes","volume":"380","author":"Wiviott","year":"2019","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.kint.2019.02.022_bib49","doi-asserted-by":"crossref","first-page":"356","DOI":"10.2337\/dc17-1096","article-title":"How does empagliflozin reduce cardiovascular mortality? Insights from a mediation analysis of the EMPA-REG OUTCOME trial","volume":"41","author":"Inzucchi","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/j.kint.2019.02.022_bib50","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.hfc.2014.04.011","article-title":"Clinical trials in patients with heart failure and preserved left ventricular ejection fraction","volume":"10","author":"Cleland","year":"2014","journal-title":"Heart Fail Clin"},{"key":"10.1016\/j.kint.2019.02.022_bib51","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1093\/eurheartj\/ehl250","article-title":"The Perindopril in Elderly People with Chronic Heart Failure (PEP-CHF) study","volume":"27","author":"Cleland","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1016\/j.kint.2019.02.022_bib52","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1056\/NEJMoa1313731","article-title":"Spironolactone for heart failure with preserved ejection fraction","volume":"370","author":"Pitt","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.kint.2019.02.022_bib53","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1016\/S0140-6736(12)61227-6","article-title":"The angiotensin receptor neprilysin inhibitor LCZ696 in heart failure with preserved ejection fraction: a phase 2 double-blind randomised controlled trial","volume":"380","author":"Solomon","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.kint.2019.02.022_bib54","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1056\/NEJMoa0805450","article-title":"Irbesartan in patients with heart failure and preserved ejection fraction","volume":"359","author":"Massie","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.kint.2019.02.022_bib55","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/S0140-6736(03)14285-7","article-title":"Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial","volume":"362","author":"Yusuf","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.kint.2019.02.022_bib56","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.cardfail.2008.11.003","article-title":"The influence of renal function on clinical outcome and response to beta-blockade in systolic heart failure: insights from Metoprolol CR\/XL Randomized Intervention Trial in Chronic HF (MERIT-HF)","volume":"15","author":"Ghali","year":"2009","journal-title":"J\u00a0Card Fail"},{"key":"10.1016\/j.kint.2019.02.022_bib57","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0140-6736(98)11181-9","article-title":"The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial","volume":"353","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.kint.2019.02.022_bib58","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1016\/S0735-1097(03)00241-9","article-title":"Carvedilol increases two-year survival in dialysis patients with dilated cardiomyopathy: a prospective, placebo-controlled trial","volume":"41","author":"Cice","year":"2003","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"Suppl M","key":"10.1016\/j.kint.2019.02.022_bib59","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1093\/eurheartj\/8.suppl_M.9","article-title":"Comparison of pharmacokinetic properties of beta-adrenoceptor blocking drugs","volume":"8","author":"McDevitt","year":"1987","journal-title":"Eur Heart J"},{"key":"10.1016\/j.kint.2019.02.022_bib60","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1093\/ndt\/gft515","article-title":"Hypertension in hemodialysis patients treated with atenolol or lisinopril: a randomized controlled trial","volume":"29","author":"Agarwal","year":"2014","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2019.02.022_bib61","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1681\/ASN.2014040324","article-title":"\u03b2-Blocker dialyzability and mortality in older patients receiving hemodialysis","volume":"26","author":"Weir","year":"2015","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2019.02.022_bib62","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1093\/eurheartj\/ehv268","article-title":"Association between renin-angiotensin system antagonist use and mortality in heart failure with severe renal insufficiency: a prospective propensity score-matched cohort study","volume":"36","author":"Edner","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.kint.2019.02.022_bib63","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/j.jacc.2014.01.087","article-title":"Worsening renal function and outcome in heart failure patients with preserved ejection fraction and the impact of angiotensin receptor blocker treatment","volume":"64","author":"Damman","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.kint.2019.02.022_bib64","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.116.003588","article-title":"Renin-angiotensin system inhibition, worsening renal function, and outcome in heart failure patients with reduced and preserved ejection fraction: a meta-analysis of published study data","volume":"10","author":"Beldhuis","year":"2017","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.kint.2019.02.022_bib65","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1002\/ejhf.609","article-title":"Worsening renal function and outcome in heart failure patients with reduced and preserved ejection fraction and the impact of angiotensin receptor blocker treatment: data from the CHARM-study programme","volume":"18","author":"Damman","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.kint.2019.02.022_bib66","doi-asserted-by":"crossref","first-page":"3667","DOI":"10.1161\/01.CIR.0000149806.01354.BF","article-title":"Chronic kidney disease, cardiovascular risk, and response to angiotensin-converting enzyme inhibition after myocardial infarction: the Survival And Ventricular Enlargement (SAVE) study","volume":"110","author":"Tokmakova","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.kint.2019.02.022_bib67","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.jacc.2013.11.031","article-title":"Current evidence on treatment of patients with chronic systolic heart failure and renal insufficiency: practical considerations from published data","volume":"63","author":"Damman","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.kint.2019.02.022_bib68","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1002\/ejhf.232","article-title":"Renal effects of the angiotensin receptor neprilysin inhibitor LCZ696 in patients with heart failure and preserved ejection fraction","volume":"17","author":"Voors","year":"2015","journal-title":"Eur J Heart Fail"},{"issue":"11 suppl","key":"10.1016\/j.kint.2019.02.022_bib69","first-page":"S212","article-title":"Evaluation of the treatment gap between clinical guidelines and the utilization of renin-angiotensin-aldosterone system inhibitors","volume":"21","author":"Epstein","year":"2015","journal-title":"Am J Manag Care"},{"key":"10.1016\/j.kint.2019.02.022_bib70","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1016\/0735-1097(93)90578-O","article-title":"The Quinapril Heart Failure Trial Investigators. Clinical consequences of angiotensin-converting enzyme inhibitor withdrawal in chronic heart failure: a double-blind, placebo-controlled study of quinapril","volume":"22","author":"Pflugfelder","year":"1993","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.kint.2019.02.022_bib71","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1056\/NEJMoa1005419","article-title":"Diuretic strategies in patients with acute decompensated heart failure","volume":"364","author":"Felker","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.kint.2019.02.022_bib72","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.amjcard.2015.10.059","article-title":"Torsemide versus furosemide in patients with acute heart failure (from the ASCEND-HF Trial)","volume":"117","author":"Mentz","year":"2016","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.kint.2019.02.022_bib73","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.jacc.2007.04.080","article-title":"Identification of a potential cardiac antifibrotic mechanism of torasemide in patients with chronic heart failure","volume":"50","author":"Lopez","year":"2007","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.kint.2019.02.022_bib74","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1016\/j.jacc.2013.04.086","article-title":"Safety and efficacy of eplerenone in patients at high risk for hyperkalemia and\/or worsening renal function: analyses of the EMPHASIS-HF study subgroups (Eplerenone in Mild Patients Hospitalization And SurvIval Study in Heart Failure)","volume":"62","author":"Eschalier","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.kint.2019.02.022_bib75","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"Randomized Aldactone Evaluation Study Investigators. The effect of spironolactone on morbidity and mortality in patients with severe heart failure","volume":"341","author":"Pitt","year":"1999","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.kint.2019.02.022_bib76","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1016\/j.jacc.2012.07.048","article-title":"Influence of baseline and worsening renal function on efficacy of spironolactone in patients with severe heart failure: insights from RALES (Randomized Aldactone Evaluation Study)","volume":"60","author":"Vardeny","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.kint.2019.02.022_bib77","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1053\/j.ajkd.2016.04.011","article-title":"The safety and efficacy of mineralocorticoid receptor antagonists in patients who require dialysis: a systematic review and meta-analysis","volume":"68","author":"Quach","year":"2016","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.kint.2019.02.022_bib78","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ijcard.2017.03.080","article-title":"Effect of spironolactone on the risks of mortality and hospitalization for heart failure in pre-dialysis advanced chronic kidney disease: a nationwide population-based study","volume":"238","author":"Tseng","year":"2017","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.kint.2019.02.022_bib79","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1093\/eurheartj\/ehw132","article-title":"A\u00a0randomized controlled study of finerenone vs. eplerenone in patients with worsening chronic heart failure and diabetes mellitus and\/or chronic kidney disease","volume":"37","author":"Filippatos","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.kint.2019.02.022_bib80","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.ijcard.2014.11.004","article-title":"Time to retrieve the best benefits from renin angiotensin aldosterone system (RAAS) inhibition in heart failure patients with reduced ejection fraction: lessons from randomized controlled trials and registries","volume":"177","author":"Rossignol","year":"2014","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.kint.2019.02.022_bib81","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1002\/ejhf.402","article-title":"Effect of patiromer on reducing serum potassium and preventing recurrent hyperkalaemia in patients with heart failure and chronic kidney disease on RAAS inhibitors","volume":"17","author":"Pitt","year":"2015","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.kint.2019.02.022_bib82","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1001\/jama.2014.15688","article-title":"Effect of sodium zirconium cyclosilicate on potassium lowering for 28 days among outpatients with hyperkalemia: the HARMONIZE randomized clinical trial","volume":"312","author":"Kosiborod","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.kint.2019.02.022_bib83","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.kint.2015.11.018","article-title":"Treatment of hyperkalemia: something old, something new","volume":"89","author":"Sterns","year":"2016","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2019.02.022_bib84","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1161\/CIRCHEARTFAILURE.113.000507","article-title":"Prevalence and prognostic importance of changes in renal function after mechanical circulatory support","volume":"7","author":"Brisco","year":"2014","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.kint.2019.02.022_bib85","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1001\/jamainternmed.2017.4831","article-title":"Outcomes associated with left ventricular assist devices among recipients with and without end-stage renal disease","volume":"178","author":"Bansal","year":"2018","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.kint.2019.02.022_bib86","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1056\/NEJMoa0907845","article-title":"A\u00a0trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease","volume":"361","author":"Pfeffer","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.kint.2019.02.022_bib87","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1056\/NEJMoa0908355","article-title":"Ferric carboxymaltose in patients with heart failure and iron deficiency","volume":"361","author":"Anker","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.kint.2019.02.022_bib88","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1093\/eurheartj\/ehu385","article-title":"Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency","volume":"36","author":"Ponikowski","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.kint.2019.02.022_bib89","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1002\/ejhf.229","article-title":"The impact of intravenous ferric carboxymaltose on renal function: an analysis of the FAIR-HF study","volume":"17","author":"Ponikowski","year":"2015","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.kint.2019.02.022_bib90","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/ejhf.823","article-title":"Effects of ferric carboxymaltose on hospitalisations and mortality rates in iron-deficient heart failure patients: an individual patient data meta-analysis","volume":"20","author":"Anker","year":"2018","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.kint.2019.02.022_bib91","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.kint.2015.10.002","article-title":"Iron management in chronic kidney disease: conclusions from a \u201cKidney Disease: Improving Global Outcomes\u201d (KDIGO) Controversies Conference","volume":"89","author":"Macdougall","year":"2016","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2019.02.022_bib92","doi-asserted-by":"crossref","first-page":"3321","DOI":"10.1128\/MCB.00432-13","article-title":"Activation of hypoxia response in endothelial cells contributes to ischemic cardioprotection","volume":"33","author":"Kerkela","year":"2013","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.kint.2019.02.022_bib93","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1056\/NEJMoa1205624","article-title":"Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis","volume":"367","author":"Chertow","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.kint.2019.02.022_bib94","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1046\/j.1523-1755.2003.00321.x","article-title":"Effect of starting with hemodialysis compared with peritoneal dialysis in patients new on dialysis treatment: a randomized controlled trial","volume":"64","author":"Korevaar","year":"2003","journal-title":"Kidney Int"},{"issue":"5S1","key":"10.1016\/j.kint.2019.02.022_bib95","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1053\/j.ajkd.2016.05.025","article-title":"Intensive hemodialysis, left ventricular hypertrophy, and cardiovascular disease","volume":"68","author":"McCullough","year":"2016","journal-title":"Am J Kidney Dis"},{"issue":"5S1","key":"10.1016\/j.kint.2019.02.022_bib96","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1053\/j.ajkd.2016.05.021","article-title":"Intensive hemodialysis and treatment complications and tolerability","volume":"68","author":"Morfin","year":"2016","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.kint.2019.02.022_bib97","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.2215\/CJN.04470709","article-title":"Hemodialysis-induced repetitive myocardial injury results in global and segmental reduction in systolic cardiac function","volume":"4","author":"Burton","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2019.02.022_bib98","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.2215\/CJN.00200115","article-title":"Randomized controlled trial of individualized dialysate cooling for cardiac protection in hemodialysis patients","volume":"10","author":"Odudu","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2019.02.022_bib99","doi-asserted-by":"crossref","first-page":"3437","DOI":"10.1681\/ASN.2005040439","article-title":"Comorbid conditions in kidney transplantation: association with graft and patient survival","volume":"16","author":"Wu","year":"2005","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2019.02.022_bib100","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1097\/TP.0b013e3182a688e5","article-title":"Predictors of graft failure and death in elderly kidney transplant recipients","volume":"96","author":"Faravardeh","year":"2013","journal-title":"Transplantation"},{"key":"10.1016\/j.kint.2019.02.022_bib101","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1097\/01.tp.0000295748.42884.97","article-title":"The impact of left ventricular systolic dysfunction on survival after renal transplantation","volume":"84","author":"Siedlecki","year":"2007","journal-title":"Transplantation"},{"key":"10.1016\/j.kint.2019.02.022_bib102","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1053\/j.ajkd.2005.06.019","article-title":"De novo congestive heart failure after kidney transplantation: a common condition with poor prognostic implications","volume":"46","author":"Lentine","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.kint.2019.02.022_bib103","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1097\/TP.0b013e31817ef0f9","article-title":"Obesity and cardiac risk after kidney transplantation: experience at one center and comprehensive literature review","volume":"86","author":"Lentine","year":"2008","journal-title":"Transplantation"},{"key":"10.1016\/j.kint.2019.02.022_bib104","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1681\/ASN.V1341084","article-title":"Congestive heart failure in renal transplant recipients: risk factors, outcomes, and relationship with ischemic heart disease","volume":"13","author":"Rigatto","year":"2002","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2019.02.022_bib105","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S1047-2797(01)00272-1","article-title":"Hospitalized congestive heart failure after renal transplantation in the United States","volume":"12","author":"Abbott","year":"2002","journal-title":"Ann Epidemiol"},{"key":"10.1016\/j.kint.2019.02.022_bib106","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/j.mcna.2004.04.016","article-title":"Risk factors for heart failure","volume":"88","author":"Kenchaiah","year":"2004","journal-title":"Med Clin North Am"},{"key":"10.1016\/j.kint.2019.02.022_bib107","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/j.mcna.2004.06.001","article-title":"The global epidemiology of heart failure","volume":"88","author":"Young","year":"2004","journal-title":"Med Clin North Am"},{"key":"10.1016\/j.kint.2019.02.022_bib108","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1093\/eurjhf\/hfr088","article-title":"Hypoalbuminaemia and incident heart failure in older adults","volume":"13","author":"Filippatos","year":"2011","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.kint.2019.02.022_bib109","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.1097\/01.ASN.0000083008.25305.67","article-title":"Early renal insufficiency and hospitalized heart disease after renal transplantation in the era of modern immunosuppression","volume":"14","author":"Abbott","year":"2003","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2019.02.022_bib110","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1161\/CIR.0b013e31823eb07a","volume":"126","author":"Lentine","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.kint.2019.02.022_bib111","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1053\/j.ajkd.2007.04.013","article-title":"ACE inhibitors and persistent left ventricular hypertrophy after renal transplantation: a randomized clinical trial","volume":"50","author":"Paoletti","year":"2007","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.kint.2019.02.022_bib112","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1097\/TP.0000000000001043","article-title":"Evaluation and management of pulmonary hypertension in kidney transplant candidates and recipients: concepts and controversies","volume":"101","author":"Lentine","year":"2017","journal-title":"Transplantation"},{"key":"10.1016\/j.kint.2019.02.022_bib113","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1016\/j.jacc.2015.08.022","article-title":"Reverse left ventricular remodeling after kidney transplantation: unraveling the complex autointoxication of uremia","volume":"66","author":"Katz","year":"2015","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.kint.2019.02.022_bib114","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/j.jacc.2004.11.061","article-title":"Effect of kidney transplantation on left ventricular systolic dysfunction and congestive heart failure in patients with end-stage renal disease","volume":"45","author":"Wali","year":"2005","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.kint.2019.02.022_bib115","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1016\/j.jacc.2015.08.023","article-title":"Reverse remodeling and prognosis following kidney transplantation in contemporary patients with cardiac dysfunction","volume":"66","author":"Hawwa","year":"2015","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.kint.2019.02.022_bib116","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1097\/00007890-199511000-00005","article-title":"Impact of renal transplantation on uremic cardiomyopathy","volume":"60","author":"Parfrey","year":"1995","journal-title":"Transplantation"},{"key":"10.1016\/j.kint.2019.02.022_bib117","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.2215\/CJN.01400308","article-title":"Renal transplantation is not associated with regression of left ventricular hypertrophy: a magnetic resonance study","volume":"3","author":"Patel","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2019.02.022_bib118","first-page":"74","article-title":"Effect of renal transplantation on left ventricular function in hemodialysis patients","volume":"18","author":"Lai","year":"1982","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.kint.2019.02.022_bib119","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1136\/pgmj.61.716.525","article-title":"Improved cardiac function after renal transplantation","volume":"61","author":"Fleming","year":"1985","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.kint.2019.02.022_bib120","doi-asserted-by":"crossref","first-page":"279","DOI":"10.5694\/j.1326-5377.1991.tb121093.x","article-title":"Improved left ventricular function after renal transplantation","volume":"154","author":"Van Den Broek","year":"1991","journal-title":"Med J Aust"},{"key":"10.1016\/j.kint.2019.02.022_bib121","first-page":"1034","article-title":"Reversal of myocardial dysfunction following renal transplantation","volume":"25","author":"Abouna","year":"1993","journal-title":"Transplant Proc"},{"key":"10.1016\/j.kint.2019.02.022_bib122","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1046\/j.1540-8175.2001.00457.x","article-title":"The effect of kidney transplant on cardiac function: an echocardiographic perspective","volume":"18","author":"Sahagun-Sanchez","year":"2001","journal-title":"Echocardiography"},{"key":"10.1016\/j.kint.2019.02.022_bib123","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.1016\/S0041-1345(02)03478-4","article-title":"Kidney transplantation in patients with ventricular ejection fraction less than 50 percent: features and posttransplant outcome","volume":"34","author":"Melchor","year":"2002","journal-title":"Transplant Proc"},{"key":"10.1016\/j.kint.2019.02.022_bib124","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1016\/S0041-1345(02)03223-2","article-title":"Improvement of left ventricular function and arterial blood pressure 1 year after simultaneous pancreas kidney transplantation","volume":"34","author":"Oppert","year":"2002","journal-title":"Transplant Proc"},{"key":"10.1016\/j.kint.2019.02.022_bib125","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/j.transproceed.2004.12.201","article-title":"Cardiovascular effects of successful renal transplantation: a 30-month study on left ventricular morphology, systolic and diastolic functions","volume":"37","author":"Dudziak","year":"2005","journal-title":"Transplant Proc"},{"key":"10.1016\/j.kint.2019.02.022_bib126","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.amjcard.2012.02.067","article-title":"Effect of renal transplantation for chronic renal disease on left ventricular mass","volume":"110","author":"Vaidya","year":"2012","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.kint.2019.02.022_bib127","doi-asserted-by":"crossref","first-page":"635","DOI":"10.7326\/0003-4819-111-8-635","article-title":"Reversal of left ventricular dysfunction after renal transplantation","volume":"111","author":"Burt","year":"1989","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.kint.2019.02.022_bib128","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1111\/ajt.12522","article-title":"Heart and combined heart-kidney transplantation in patients with concomitant renal insufficiency and end-stage heart failure","volume":"14","author":"Schaffer","year":"2014","journal-title":"Am J Transplant"},{"key":"10.1016\/j.kint.2019.02.022_bib129","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1016\/j.athoracsur.2014.09.026","article-title":"The survival benefit of\u00a0simultaneous heart-kidney transplantation extends beyond\u00a0dialysis-dependent patients","volume":"99","author":"Kilic","year":"2015","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.kint.2019.02.022_bib130","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1053\/j.ajkd.2007.11.001","article-title":"Excerpts from the United States Renal Data System 2007 annual data report","volume":"51","author":"Collins","year":"2008","journal-title":"Am J Kidney Dis"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253819302765?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253819302765?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T00:52:16Z","timestamp":1758761536000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253819302765"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":129,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["S0085253819302765"],"URL":"https:\/\/doi.org\/10.1016\/j.kint.2019.02.022","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Heart failure in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference","name":"articletitle","label":"Article Title"},{"value":"Kidney International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.kint.2019.02.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier Inc. on behalf of the International Society of Nephrology.","name":"copyright","label":"Copyright"}]}}